Urologix' Building Momentum, New COO Help Boost Stock 63% In November
This article was originally published in The Gray Sheet
Executive Summary
Continued momentum in sales of Urologix' Targis microwave catheter-based system for treatment of benign prostatic hyperplasia and procedure kit revenues, as well as growing acceptance of a "per-procedure" marketing strategy and strong additions to top management, helped Urologix stock jump 62.7% in November. The issue gained 2 points to close at 5-3/16